Veronica Bisagno
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Veronica Bisagno has a total of 17 co-authors. Here are the top co-authors by number of shared publications:
- Francisco José Urbano
IFIByNE, Universidad de Buenos Aires, Buenos Aires, Argentina, Argentina
4 shared publications Ignacio Carrera
Departamento de Química Orgánica, Facultad de Química, Universidad de la República, 11800, Montevideo, Uruguay
2 shared publications- Maria Sofia Villalba
IIMT, Austral University, Buenos Aires, Argentina, Argentina
2 shared publications Pablo Torterolo
Departamento de Fisiología, Facultad de Medicina, Universidad de la República, Montevideo, 11200, Uruguay
2 shared publicationsSofía Villalba
Instituto de Investigaciones en Medicina Traslacional, Facultad de Ciencias Biomédicas, CONICET-Universidad Austral, Buenos Aires, Argentina
2 shared publicationsAgustín Martínez Christensen
Instituto de Investigaciones en Medicina Traslacional, Facultad de Ciencias Biomédicas, CONICET-Universidad Austral, Buenos Aires, Argentina
1 shared publication
Latest Publications
- Open Access
- 15 September 2026
- Published by MDPI AG in Preprints.org
Systemic HDAC Inhibition Changes Glutamatergic Neuronal Properties in Prefrontal Cortex and Ventrobasal Thalamus
Reversible protein acetylation controlled by histone deacetylases (HDACs) regulates neuronal gene expression and, increasingly, membrane physiology. We previously showed that pedunculopontine nucleus (PPN) gamma-band oscillations require class IIa HDAC activity, whereas class I inhibition was comparatively benign for that readout. Whether systemic HDAC inhibition acts uniformly across the forebrain, and across different neuronal nuclei, is unknown. Here we administered acute single systemic doses of the class I inhibitor MS275 (entinostat) and the class IIa inhibitor MC1568 to mice and performed whole-cell recordings in two functionally distinct, anatomically unconnected structures: medial prefrontal cortex (mPFC) and the ventrobasal complex (VB) of the thalamus. In mPFC pyramidal neurons we assessed short-term plasticity using paired-pulse stimulation and quantifying paired-pulse ratio (PPR); in VB neurons we quantified action-potential amplitude and the maximal rate of rise of the spike from phase-plot analysis. MS275 shifted PPR from facilitation toward depression on both mPFC and VB glutamatergic transmission, a significant change relative to vehicle, while MC1568 produced an intermediate, non-significant effect. In addition, MS275 reduced action-potential amplitude and markedly decreased the maximal rate of rise (dV/dt) of the spike in VB neurons. Thus, class I HDAC inhibition predominantly affected presynaptic glutamate release whilst affecting intrinsic properties of thalamocortical neurons. These results suggest that the consequences of systemic HDAC inhibition are class- and region-specific.
- 15 September 2026
- Published by MDPI AG in Preprints.org
Open AccessSystemic HDAC Inhibition Changes Glutamatergic Neuronal Properties in Prefrontal Cortex and Ventrobasal Thalamus
Reversible protein acetylation controlled by histone deacetylases (HDACs) regulates neuronal gene expression and, increasingly, membrane physiology. We previously showed that pedunculopontine nucleus (PPN) gamma-band oscillations require class IIa HDAC activity, whereas class I inhibition was comparatively benign for that readout. Whether systemic HDAC inhibition acts uniformly across the forebrain, and across different neuronal nuclei, is unknown. Here we administered acute single systemic doses of the class I inhibitor MS275 (entinostat) and the class IIa inhibitor MC1568 to mice and performed whole-cell recordings in two functionally distinct, anatomically unconnected structures: medial prefrontal cortex (mPFC) and the ventrobasal complex (VB) of the thalamus. In mPFC pyramidal neurons we assessed short-term plasticity using paired-pulse stimulation and quantifying paired-pulse ratio (PPR); in VB neurons we quantified action-potential amplitude and the maximal rate of rise of the spike from phase-plot analysis. MS275 shifted PPR from facilitation toward depression on both mPFC and VB glutamatergic transmission, a significant change relative to vehicle, while MC1568 produced an intermediate, non-significant effect. In addition, MS275 reduced action-potential amplitude and markedly decreased the maximal rate of rise (dV/dt) of the spike in VB neurons. Thus, class I HDAC inhibition predominantly affected presynaptic glutamate release whilst affecting intrinsic properties of thalamocortical neurons. These results suggest that the consequences of systemic HDAC inhibition are class- and region-specific.
- 9 July 2026
- Published by Elsevier in Pharmacology Biochemistry and Behavior
- Vol. 267, 174232
Psychedelics and the thalamocortical system: A scoping review
- 9 July 2026
- Published by Elsevier in Pharmacology Biochemistry and Behavior
- Vol. 267, 174232
Psychedelics and the thalamocortical system: A scoping review
- 9 August 2025
- Published by Elsevier in Progress in Neuro-Psychopharmacology and Biological Psychiatry
- Vol. 141, 111467
Noribogaine altered intrinsic properties of thalamocortical neurons in a sex-dependent manner
- 9 August 2025
- Published by Elsevier in Progress in Neuro-Psychopharmacology and Biological Psychiatry
- Vol. 141, 111467
Noribogaine altered intrinsic properties of thalamocortical neurons in a sex-dependent manner
- Open Access
- 5 January 2024
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 25 (2) , 687
5-HT2A Receptor Knockout Mice Show Sex-Dependent Differences following Acute Noribogaine Administration
Noribogaine (noribo) is the primary metabolite from ibogaine, an atypical psychedelic alkaloid isolated from the root bark of the African shrub Tabernanthe iboga. The main objective of this study was to test the hypothesis that molecular, electrophysiological, and behavioral responses of noribo are mediated by the 5-HT2A receptor (5-HT2AR) in mice. In that regard, we used male and female, 5-HT2AR knockout (KO) and wild type (WT) mice injected with a single noribo dose (10 or 40 mg/kg; i.p.). After 30 min., locomotor activity was recorded followed by mRNA measurements by qPCR (immediate early genes; IEG, glutamate receptors, and 5-HT2AR levels) and electrophysiology recordings of layer V pyramidal neurons from the medial prefrontal cortex. Noribo 40 decreased locomotion in male, but not female WT. Sex and genotype differences were observed for IEG and glutamate receptor expression. Expression of 5-HT2AR mRNA increased in the mPFC of WT mice following Noribo 10 (males) or Noribo 40 (females). Patch-clamp recordings showed that Noribo 40 reduced the NMDA-mediated postsynaptic current density in mPFC pyramidal neurons only in male WT mice, but no effects were found for either KO males or females. Our results highlight that noribo produces sexually dimorphic effects while the genetic removal of 5HT2AR blunted noribo-mediated responses to NMDA synaptic transmission.
- 5 January 2024
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 25 (2) , 687
Open Access5-HT2A Receptor Knockout Mice Show Sex-Dependent Differences following Acute Noribogaine Administration
Noribogaine (noribo) is the primary metabolite from ibogaine, an atypical psychedelic alkaloid isolated from the root bark of the African shrub Tabernanthe iboga. The main objective of this study was to test the hypothesis that molecular, electrophysiological, and behavioral responses of noribo are mediated by the 5-HT2A receptor (5-HT2AR) in mice. In that regard, we used male and female, 5-HT2AR knockout (KO) and wild type (WT) mice injected with a single noribo dose (10 or 40 mg/kg; i.p.). After 30 min., locomotor activity was recorded followed by mRNA measurements by qPCR (immediate early genes; IEG, glutamate receptors, and 5-HT2AR levels) and electrophysiology recordings of layer V pyramidal neurons from the medial prefrontal cortex. Noribo 40 decreased locomotion in male, but not female WT. Sex and genotype differences were observed for IEG and glutamate receptor expression. Expression of 5-HT2AR mRNA increased in the mPFC of WT mice following Noribo 10 (males) or Noribo 40 (females). Patch-clamp recordings showed that Noribo 40 reduced the NMDA-mediated postsynaptic current density in mPFC pyramidal neurons only in male WT mice, but no effects were found for either KO males or females. Our results highlight that noribo produces sexually dimorphic effects while the genetic removal of 5HT2AR blunted noribo-mediated responses to NMDA synaptic transmission.